NO-donating genistein prodrug alleviates bone loss in ovariectomised rats

Swiss Medical Weekly

Volumn 138, Issue 41-42, 2008, Pages 602-607

  Wang, Jiepin ^a   Shang, Fujun ^b   Mei, Qibing ^a   Wang, Jianbo ^a   Zhang, Rong ^a   Wang, Siwang ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone loss; Bone mineral density; Mechanical strength; NO donating genistein prodrug; Ovariectomised rats; Postmenopausal osteoporosis; Serum biomarkers

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; BIOLOGICAL MARKER; DEOXYPYRIDINOLINE; GENISTEIN; NITRIC OXIDE DONOR; OSTEOCALCIN; PRODRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BODY WEIGHT; BONE DENSITY; BONE STRENGTH; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; FEMALE; FEMUR; HORMONE SUBSTITUTION; MECHANICAL STIMULATION; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; RAT; TIBIA; TREATMENT DURATION; UTERUS;

EID: 54349096629     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-3.
2. Oerter Klein K, Janfaza M, Wong JA, Chang RJ. Oestrogen bioactivity in fo-ti and other herbs used for their oestrogen-like effects as determined by a recombinant cell bioassay. J Clin Endocrinol Metab. 2003; 88(9):4077-9.
3. Ho SC, Lau EM, Woo J, Sham A, Chan KM, Lee S, et al. The prevalence of osteoporosis in the Hong Kong Chinese female population. Maturitas. 1999; 32:171-8.
4. Ho SC, Chan SG., Yi Q, Wong E, Leung PC. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J Bone Miner Res. 2001;16:1363-9.
5. Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporos Int. 2000;11:721-4.
6. Dang ZC, Lowik C. Dose-dependent effects of phytoestrogens on bone. Trends Endocrinol Metab. 2005;16:207-13.
7. Stopper H, Schmitt E, Kobras K. Genotoxicity of phytoestrogens. Mutat Res / Fundamental and Molecular Mechanisms of Mutagenesis 2005;574:139-55.
8. Vallance P. Nitric oxide in the human cardiovascular system - SKB lecture 1997. Br J Clin Pharmacol. 1998;45:433-9.
9. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 -estradiol and norethisterone acetate. A two year follow-up study. Hypertension. 1995;25:848-53.
10. Cicinelli E, Ignarro LJ, Schonauer LM, Matteo MG, Galantino P, Balzano G. Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril. 1998;69:58-61.
11. Cicinelli E, Matteo G, Ignarro LJ, Matteo G, Falco N, Schonauer LM. Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women. Fertil Steril. 1997;67:63-6.
12. Stacey E, Korkia P, Hukkanen MV, Polak JM, Rutherford OM. Decreased nitric oxide levels and bone turnover in amenorrhoeic athletes with spinal osteopenia. J Clin Endocrinol Metab. 1998;83:3056-61.
13. Lowik CW, Nibbering PH, van de Ruit M, Papapoulos SE. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. J Clin Invest. 1994;93:1465-72.
14. Kasten TP, Collin-Osdoby, Patel N, Osdoby P, Krukowski M, Misko TP, et al. Potentiation of osteoclastic bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci. USA 1994;91:3569-73.
15. MacIntyre I, Zaidi M, Alam ASMT, Dana HK, Moonga BS, Lidbury PS, et al. Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc Natl Acad Sci. USA 1991;88:2936-40.
16. Hukkanen M, Platts LA, Lawes T, Girgis SI, Konttinen YT, Goodship AE, et al. Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of oestrogen deficiency-induced osteopenia. Bone. 2003;32:142-9.
17. Wimalawansa SJ, De Marco G, Gangula P, Yallampalli C. Nitric oxide donor alleviates ovariectomy-induced bone loss. Bone. 1996;18:301-4.
18. O'Shaughnessy, MC, Polak JM, Afzal F, Hukkanen MV, Huang P, MacIntyre I, et al. Nitric oxide mediates 17 -estradiol stimulated human and rodent osteoblast proliferation and differentiation. Biochem Biophys Res Commun. 2000;277:604-10.
19. Armour KE, Armour KJ, Gallagher ME, Godecke A, Helfrich MH, Reid DM, et al. Defective bone formation and anabolic response to exogenous oestrogen in mice with targeted disruption of endothelial nitric oxide synthase. Endocrinology. 2001;142:760-6.
20. Aguirre J, Buttery L, O'Shaughnessy M, Afzal F, Fernandez de Marticorena I, Hukkanen M, et al. Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity. Am J Pathos. 2001;158:247-57.
21. JP Wang, FJ Shang, R Jiang, L Liu, SW Wang, J Hou, ML Huan, QB Mei. NO-donating Genistein Prodrug: Design, Synthesis and Bioactivity on MC3T3-E1 cells. J Pharmacol Sci. 2007;104:829.
22. Carini M, Aldini G, Stefani R., Orioli M, Facino RM. Nitrosylhemoglobin, an unequivocal index of nitric oxide release from nitroaspirin: in vitro and in vivo studies in the rat by ESR spectroscopy. J Pharm Biomed Anal. 2001;26:509-18.
23. Wang ZL, Sun JY, Wang DN, Xie YH, Wang SW, Zhao WM. Pharmacological studies of the large-scaled purified genistein from Huaijiao (Sophora japonica - Leguminosae) on anti-osteoporosis. Phytomedicine. 2006;13:718-23.
24. Kasra M, Vanin CM, MacLusky NJ, Casper RF, Grynpas MD. Effect of different oestrogen and progestin regimens on the mechanical properties of rat femur. J Orthop Res. 1997;15:118-23.
25. Teramura K, Fukushima S, Nozaki K, Kokubo S, Takahashi K. Comparison of incadronate and alfacalcidol on increased bone turnover caused by ovariectomy in rats. Eur J Pharmacol. 2002;449:191-6.
26. Teramura K, Fukushima S, Iwai T, Nozaki K, Kokubo S, Takahashi K. Incadronate inhibits osteoporosis in ovariectomised rats. Eur J Pharmacol. 2002;457:51-6.
27. Shirwaikar A, Khan S, Malini S. Antiosteoporotic effect of ethanol extract of Cissus quadrangularis Linn. on ovariectomised rat. J Ethnopharmacol. 2003;89:245-50.